Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

2026 data Public-data reference. official source

Cigarette Smoking

Open-data reference.

46 US clinical trials · 20 currently recruiting

Active & Recent Trials

RECRUITING NA 544 participants

A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse

Medical University of South Carolina

NCT06118502

RECRUITING NA 482 participants

The Positively Quit Trial for Smoking Cessation

University of South Florida

NCT04449458

RECRUITING NA 472 participants

Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit

Abramson Cancer Center at Penn Medicine

NCT07199517

RECRUITING NA 316 participants

Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing

Virginia Polytechnic Institute and State University

NCT07142668

RECRUITING Phase 2 302 participants

E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

NYU Langone Health

NCT05722561

RECRUITING NA 225 participants

Switch or Quit R01

Medical University of South Carolina

NCT06373679

RECRUITING NA 210 participants

The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers

Abramson Cancer Center at Penn Medicine

NCT06264154

RECRUITING NA 200 participants

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

Abramson Cancer Center at Penn Medicine

NCT06372899

RECRUITING Phase 2 197 participants

Semaglutide for Post-Smoking Cessation Weight Management

The University of Texas Health Science Center, Houston

NCT06173778

RECRUITING Phase 1 100 participants

Effect of Cannabis on Cigarette Use Behavior

Johns Hopkins University

NCT06609083

RECRUITING Phase 4 80 participants

Beta-Adrenergic Modulation of Drug Cue Reactivity

University of Oklahoma

NCT05587361

RECRUITING NA 70 participants

Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing

Virginia Polytechnic Institute and State University

NCT07161050

RECRUITING NA 68 participants

Menthol, Inflammation, and Nicotine Transition Study

Rosalind Franklin University of Medicine and Science

NCT06232447

RECRUITING NA 64 participants

RTMS Targets Neural Circuits for Smoking Cessation

Medical University of South Carolina

NCT04903028

RECRUITING NA 60 participants

E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness

NYU Langone Health

NCT05815199

RECRUITING NA 50 participants

Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches

Medical University of South Carolina

NCT06678789

RECRUITING NA 48 participants

Smoking Cessation Intervention for American Indian Women Experiencing Intimate Partner Violence

Black Hills Center for American Indian Health

NCT06357767

RECRUITING NA 46 participants

Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

University of Chicago

NCT06395415

RECRUITING Phase 1 40 participants

Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use

Yale University

NCT06027840

RECRUITING NA 30 participants

Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures

Masonic Cancer Center, University of Minnesota

NCT06295757

ACTIVE NOT RECRUITING NA 940 participants

Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks

University of Colorado, Denver

NCT05641974

ACTIVE NOT RECRUITING NA 150 participants

Are Smokers Switching to Vaping at Lower Risk for Cancer? (Electronic Cigarettes and Cancer Risk)

University of Southern California

NCT03750825

COMPLETED NA 789 participants

The Effectiveness of Smoking Cessation Guidelines in the Emergency Department

University of Iowa

NCT00756704

COMPLETED NA 397 participants

Smoking Interventions for Hospital Patients

Massachusetts General Hospital

NCT01177176

COMPLETED NA 246 participants

Use and Harm Exposure in New Low Nicotine Cigarettes

University of Pennsylvania

NCT01202942

COMPLETED Phase 4 203 participants

Smoking Study With Behavioral Therapy for Hypertensive Patients

UConn Health

NCT00879177

COMPLETED NA 190 participants

Reducing Tobacco Use Disparities Among Low-Income Adults

Northwestern University

NCT03077737

COMPLETED NA 180 participants

Resistance Training as an Aid to Smoking Cessation Treatment

Teachers College, Columbia University

NCT01951456

COMPLETED NA 171 participants

Cigarette Smoking Among Young Adults

University of Oklahoma

NCT04340947

COMPLETED Phase 2 165 participants

Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties

University of Oklahoma

NCT05095779

COMPLETED Phase 2 150 participants

Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment

Brown University

NCT00938886

COMPLETED Phase 2 142 participants

Treatment of Smoking Among Individuals With PTSD

University of Pennsylvania

NCT00937235

COMPLETED Early Phase 1 87 participants

Testing the ETM: Examination and Comparison of Different Methods

Virginia Polytechnic Institute and State University

NCT05946031

COMPLETED Phase 1 77 participants

Text Messaging-Based Smoking Cessation Program for Homeless Youth

RAND

NCT03874585

COMPLETED Phase 2 77 participants

E-cigarette Nicotine Study

University of Vermont

NCT04709471

COMPLETED NA 59 participants

Contingency Management and Pharmacotherapy for Smoking Cessation

UConn Health

NCT00683280

COMPLETED 50 participants

Brain Nicotine Receptor Density & Response to Nicotine Patch

Brentwood Biomedical Research Institute

NCT01526005

COMPLETED Phase 2 48 participants

Semaglutide for Alcohol Use Disorder

University of North Carolina, Chapel Hill

NCT05520775

COMPLETED Phase 2 38 participants

Treating Smokers With Mental Illness

University of Minnesota

NCT03822416

COMPLETED NA 36 participants

A Study to Assess the Pharmacokinetics of Oral Nicotine Pouches and Lozenges in Healthy Adults

British American Tobacco (Investments) Limited

NCT04755348

COMPLETED Phase 1 33 participants

Contingency Management, Quitting Smoking, and ADHD

Duke University

NCT02266784

COMPLETED NA 29 participants

Families With Substance Use and Psychosis: A Pilot Study

Mclean Hospital

NCT04284813

COMPLETED Phase 1 26 participants

New Approaches to Smoking Cessation in Heavy Drinkers

Yale University

NCT02151591

COMPLETED NA 17 participants

E-cigarettes for Harm Reduction in Adults With Asthma

Brown University

NCT05278065

COMPLETED Phase 1 12 participants

A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers

University of North Carolina, Chapel Hill

NCT00924768

COMPLETED NA 9 participants

Behavioral Economic Methods for Assessing Tobacco Product Abuse Liability: Study 7

Virginia Polytechnic Institute and State University

NCT03496922

Phase Distribution

PhaseTrial count
Early Phase 1 7
Phase 2 8
Phase 4 2

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Cigarette Smoking Trial Landscape

ClinicalTrials.gov lists 46 US studies indexed under Cigarette Smoking, and 20 of those are currently open to recruitment — roughly 43% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Cigarette Smoking shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 15 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Cigarette Smoking is led by Medical University of South Carolina with 4 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 46 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Cigarette Smoking?

PlainTrial tracks 46 US clinical trials for Cigarette Smoking, of which 20 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Cigarette Smoking?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →